NSETrading Plan under PIT30 Sept 2026 · 30 Sept 2026, 05:19 pm

Trading Plan under PIT

Medicamen Biotech Limited · MEDICAMEQ

✦ AI SummaryRelated Party

Medicamen Biotech Limited has informed the Exchange regarding Trading Plan pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, disclosing a sale of 70,000 equity shares by Director Sanjay Bansal.

Analysis Scores

Earnings Impact2/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Medicamen Biotech Limited has informed the Exchange regarding Trading Plan pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

MEDICAMEQ_30092026171905_3051_001.pdf

pdf

Download →
View document text
FORM C SEBI (Prohibition of Insider Trading) Regulations, 2015 [Regulation 7 (2) read with Regulation 6(2) – Continual disclosure] Name of the company: Medicamen Biotech Limited ISIN of the company: INE646B01010 Details of change in holding of Securities of Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2). Name, Category of Securities held Securities acquired/Disposed Securities held post Date of allotment Date of Mode of PAN, Person prior to acquisition/disposal advice/ intimation acquisition / CIN/DIN, (Promoters/ acquisition/disposal acquisition of to disposal (on & address KMP / shares/ company market/public with Directors/ sale of shares / contact immediate specify rights/ nos. Relative preferential to/others offer / off Type of No. Type of No. Value (In Transact Type of No. and % From To etc.) and % market/ Inter- security security Rs.) ion security of of se (For eg. Type (For eg.– shareholdin shareholdi (For eg.– transfer, –Shares, ng Shares, (Buy/ Shares, g ESOPs Warrants, Warrants, Sale/ Warrants, etc.) Convertible Pledge / Convertib Convertibl Debentures e Revoke/ le etc.) Debenture Invoke) Debenture s etc.) s etc.) Name: Sanjay Director Equity shares 1,02,813 Equity 32,813 1,05,42,440 Sale Equity 70,000 (0.51) 28.09.2026 30.09.2026 30.09.2026 On market Bansal S/o Late Equity Shares Equity Shares (One Crore Shares Mr. Kedar Nath Shares Five Lakhs 0.76% Forty-Two PAN: Thousand AELPB1342K Four Hundred and Address: House Forty) No. 5, First Floor, Road No.- 65, Punjabi Bagh West, New Delhi- 110026 Contact No.: +919810061262 E-mail: sbansalindia@ya hoo.com Note: “Securities” shall have the meaning as defined under regulation 2(1)(i) of SEBI (Prohibition of Insider Trading) Regulations, 2015. Details of trading in derivatives of the company by Promoter, Employee or Director of a listed company and othersuch persons as mentioned in Regulation 6(2). Exchange on which Trading in derivatives (Specify type of contract, Futures or Options etc) thetrade was executed Buy Sell Type of Contract Number of units Number of units contract specifications Notional Value (contracts * lot Notional Value (contracts * lot size) size) NA NA NA NA NA NA NA Note: In case of Options, notional value shall be calculated based on Premium plus strike price of options. Yours faithfully Sanjay Bansal Director DIN: 00121667 Date: 30.09.2026 Place: New Delhi ******